As of December 31, 2024, the Company had 502 retail stores in 150 cities, 478 servicing centers and Li Auto-authorized body and paint shops operating in 225 cities. The Company also had 1,727 super ...

NYP will be the first polytechnic to receive the official certification of a Dolby Atmos 7.1.4 Surround Audio Studio – to ...

Basel, January 13, 2025 – Novartis is pleased with the decision by the US Court of Appeals for the Federal Circuit (CAFC) that affirms the validity of the Entresto ® (sacubitril/valsartan) combination ...

Idorsia will call a bondholder meeting in accordance with articles 1164 et seqq. of the Swiss Code of Obligations and will propose to the bondholders to modify the terms of the Bonds to, among others, ...

W&T Offshore, Inc. (NYSE: WTI) (“W&T Offshore” or the “Company”) today announced its intention to offer, subject to market and other conditions, $350 million in aggregate principal amount of senior ...

Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) today announces that it has entered into an agreement with Curium Pharma for the transfer of marketing and distribution rights ...

SINGAPORE, Jan. 13, 2025 /PRNewswire/ -- Pollo AI, an innovative leader in AI-powered video generation, today announced the launch of a new feature that allows users to select from a range of ...

In January 2025, SUS ENVIRONMENT launches new global brand identity. This renewal improves the brand image and enriches the brand connotation, bolstering its commitment to global sustainable ...

E Ink (8069.TWO), the originator, pioneer, and global commercial leader in ePaper technology, today announced they will be ...

Global Biopharmaceutical Logistics Market is expected to grow from US$ 95.66 Bn in 2022 to US$ 171.89 Bn by 2031, at a CAGR of 6.5% during the forecast period 2023-2031. A Request of this Sample PDF ...

Under the terms of the agreement, Biohaven is responsible for the preclinical ADC generation of three Merus bispecific antibodies under mutually agreed research plans. The agreement includes two Merus ...

Caribou has initiated the GALLOP Phase 1 clinical trial, an open-label, multicenter clinical trial designed to evaluate a single infusion of CB-010 in adult patients with LN and ERL. CB-011, a ...